SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-020241
Filing Date
2021-05-20
Accepted
2021-05-20 18:22:03
Documents
2
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 EX-24 DOCUMENT attachment1.htm EX-24 4019
  Complete submission text file 0000899243-21-020241.txt   6961
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ATEA PHARMACEUTICALS, INC. 125 SUMMER STREET BOSTON MA 02110
Business Address
Adams Jerome M. (Reporting) CIK: 0001863366 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 21945913